MethylAction

MethylAction detects differentially methylated regions (DMRs) from enrichment-based next-generation sequencing data to identify statistically significant patterns of hyper- and hypo-methylation across multiple biological groups.

Key Features:

• Multi-Group Analysis: Facilitates detection of all possible statistically significant hyper- and hypo-methylation patterns across any number of biological groups.
• Statistical Rigor: Establishes significance at the DMR level and employs bootstrapping to estimate false discovery rates (FDRs) for each methylation pattern.
• Enhanced Detection Capability: Detects a greater number of DMRs with strong differential methylation measurements than two-group methods, with findings corroborated by whole genome bisulfite sequencing (WGBS) for improved precision and recall in cross-cohort analyses.
• Application in Biological Subtype Differentiation: Has been applied to distinguish benign prostate conditions from three clinical prostate cancer subtypes, capturing molecular and gene-regulatory differences among subtypes.

Scientific Applications:

• Multi-group DNA methylation studies: Enables genome-wide comparison of methylation patterns across multiple biological groups or subtypes.
• Disease subtype characterization: Supports identification of methylation differences that separate clinical subtypes, as demonstrated in prostate cancer.
• Epigenetic mechanism investigation: Facilitates analysis of hyper- and hypo-methylation patterns to study gene-regulatory and molecular differences among conditions.
• Biomarker discovery and translational research: Provides DMR-level results useful for biomarker identification and studies aimed at personalized medicine.

Methodology:

Processes enrichment-based sequencing data (MBD-isolated genome sequencing (MiGS), MeDIP-seq), performs genome-wide DMR detection with significance testing at the DMR level, and uses bootstrapping to estimate FDRs for each methylation pattern across multiple groups.